Literature DB >> 9723929

YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells.

M Iriarte1, G R Cornelis.   

Abstract

Extracellular Yersinia disarm the immune system of their host by injecting effector Yop proteins into the cytosol of target cells. Five effectors have been described: YopE, YopH, YpkA/YopO, YopP and YopM. Delivery of these effectors by Yersinia adhering at the cell surface requires other Yops (translocators) including YopB. Effector and translocator Yops are secreted by the type III Ysc secretion apparatus, and some Yops also need a specific cytosolic chaperone, called Syc. In this paper, we describe a new Yop, which we have called YopT (35.5kDa). Its secretion required an intact Ysc apparatus and SycT (15.0kDa, pl4.4), a new chaperone resembling SycE. Infection of macrophages with a Yersinia, producing a hybrid YopT-adenylate cyclase, led to the accumulation of intracellular cAMP, indicating that YopT is delivered into the cytosol of eukaryotic cells. Infection of HeLa cells with a mutant strain devoid of the five known Yop effectors (deltaHOPEM strain) but producing YopT resulted in the alteration of the cell cytoskeleton and the disruption of the actin filament structure. This cytotoxic effect was caused by YopT and dependent on YopB. YopT is thus a new effector Yop and a new bacterial toxin affecting the cytoskeleton of eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723929     DOI: 10.1046/j.1365-2958.1998.00992.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  75 in total

1.  Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria.

Authors:  F Tafazoli; A Holmström; A Forsberg; K E Magnusson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption.

Authors:  S J Juris; A E Rudolph; D Huddler; K Orth; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 3.  Molecular and cell biology aspects of plague.

Authors:  G R Cornelis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction.

Authors:  I Sorg; U M Goehring; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis.

Authors:  Nadine Grosdent; Isabelle Maridonneau-Parini; Marie-Paule Sory; Guy R Cornelis
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

6.  Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases.

Authors:  Feng Shao; Panayiotis O Vacratsis; Zhaoqin Bao; Katherine E Bowers; Carol A Fierke; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

7.  The C terminus of YopT is crucial for activity and the N terminus is crucial for substrate binding.

Authors:  Isabel Sorg; Claudia Hoffmann; Juergen Dumbach; Klaus Aktories; Gudula Schmidt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 8.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

9.  Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.

Authors:  K L DeBord; V T Lee; O Schneewind
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

10.  Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.

Authors:  Sujin Chanchamroen; Chidchamai Kewcharoenwong; Wattanachai Susaengrat; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.